We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Advisers Recommend More Flu Drug Warnings

Law360 (November 28, 2007, 12:00 AM EST) -- A U.S. Food and Drug Administration advisory committee has recommended stronger warning labels for flu drugs sold by Roche Holding AG and GlaxoSmithKline Plc after reports showed an increase in psychotic reactions to the drugs in young patients, particularly in Japan.

On Tuesday, a majority of the FDA’s Pediatric Advisory Committee found that the current labeling for Roche’s flu drug Tamiflu does not “adequately address” safety concerns raised by reports of neuropsychiatric events experienced by patients.

The PAC recommended adding warnings to the label stating that...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.